Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Exponent (EXPO)

Exponent Q4 revenue rises 11.3% to $136.8 million; quarterly dividend raised to $0.30

Positive Impact 3 of 5 earnings Written later

Exponent reported fourth-quarter 2024 total revenues of $136.8 million, up 11.3%, and net income of $23.6 million, or $0.46 per diluted share, versus $0.41 a year earlier. The company also raised its quarterly cash dividend from $0.28 to $0.30 per share and guided to first-quarter 2025 revenues down in the low-single digits and full-year 2025 revenues growing in the low-single digits.

Key points

  • Q4 2024 total revenues rose 11.3% to $136.8 million; net income rose to $23.6 million, or $0.46 per diluted share, from $20.9 million, or $0.41
  • Quarterly dividend increased from $0.28 to $0.30 per share, payable March 21, 2025 to holders of record as of March 7, 2025
  • Q1 2025 guidance: revenues before reimbursements down in the low-single digits; EBITDA 25.0% to 26.0% of revenues before reimbursements
  • Full-year 2025 guidance: revenues before reimbursements to grow in the low-single digits; EBITDA 26.25% to 27.0%

The filing

CompanyExponent (EXPO)
Form8-K, current report
Filed with the SECFeb 6, 2025, 4:05 PM ET
Accession number0001171843-25-000676

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 06, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.